The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Case Report: A 40-Year-Old Man with Vasculitic Neuropathy

Case Report: A 40-Year-Old Man with Vasculitic Neuropathy

October 19, 2020 • By Martin Garber, DO, & David Fivenson, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Ironically, chronic exposure to minocycline has also been associated with a variety of autoimmune syndromes, including drug-induced lupus, auto­immune hepatitis, serum sickness and vasculitis.1 Minocycline is associated with an 8.5-fold increased risk of drug-induced lupus.2 Minocycline and nitrofurantoin are implicated in 90% of cases of drug-induced autoimmune hepatitis.3 Minocycline-induced vasculitis is much less common and, therefore, may not receive appropriate consideration.

You Might Also Like
  • Case Report: A 50-Year-Old Man Suffers Dye-Induced Arthritis
  • Case Study: 66-Year-Old Man with Visual Loss, Headache, Hematuria, Chronic Sinusitis
  • Case Report: Metoprolol-Induced Arthralgia
Explore This Issue
October 2020

We present a case of polyarteritis nodosa (PAN), primarily affecting the lower extremity peripheral nerves and skin, that improved only after minocycline was recognized as the culprit and stopped.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Case Presentation

A 40-year-old man presented with 10 days of pain, stiffness and swelling in his hands, wrists, shoulders, ankles and feet, along with generalized myalgias. He had a history of acne vulgaris, which had been treated with minocycline for the previous three years. His past medical history was otherwise unremarkable.

He denied having a rash, fever, chills, dyspnea, abdominal pain, chest pain or paresthesias. He had tender, non-swollen joints in his fingers, wrists, shoulders, ankles and feet.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

His initial laboratory tests showed an erythrocyte sedimentation rate of 17 mm/hr (reference range: 0–15 mm/hour in men younger than 50) and a C-reactive protein level of 3.8 mg/dL (reference range: <0.5 mg/L); rheumatoid factor (RF) and anti-nuclear antibodies (ANA) were absent. He was started on 20 mg/day of prednisone, which was tapered over four weeks and quickly felt better. He was referred to our rheumatology service for further evaluation.

At the time of his initial consult visit with us, he had finished his prednisone taper and was experiencing recurrence of his joint pain. He had no rash or joint swelling on examination. Laboratory tests were remarkable for C-reactive protein of 2.3 mg/dL, a positive ANA (titer 1:160, speckled pattern) and an elevated white blood count of 12.3×103/mcL (see Table 1). He did not have antibodies against extractable nuclear antigens, anti-nuclear cytoplasmic antibodies (ANCA), RF or anti-cyclic citrullinated peptide antibodies (ACPA). His muscle enzymes and urinalysis were both normal, as was his chest X-ray.

Patients with minocycline-associated vasculitic neuropathy respond quickly (within four to 12 weeks) to the antibiotic’s withdrawal.

He was placed back on prednisone 40 mg/day with a slow taper. Hydroxy­chloroquine 400 mg/day was started. Within eight weeks, he was able to reduce his prednisone dose to 5 mg/day without recurrence of his joint symptoms; however, he developed shooting pain, numbness and tingling in the feet and ankles. He also noticed an episodic, fleeting, erythematous exanthema on his lower extremities.

Table 1: Laboratory Tests at Presentation to the Rheumatologist

LaboratoryTest Result*Reference Range
White cell count12.3x103/mcL4.0x103/mcL–10.0x103/mcL
Hemoglobin14.8 gm/dL13.5–17.5 gm/dL
Platelet312x103/mcL140x103/mcL–450x103/mcL
Serum creatinine0.84 mg/dL0.64–1.27 mg/dL
Aspartate amniotransferase (AST)27 IU/L15–41 IU/L
Alanine aminotransferase (ALT)28 IU/L50–280 IU/L
Uric acid3.3 mg/dL1.2–7.6 mg/dL
Creatine phosphokinase (CK)81 IU/L50–280 IU/L
Alsolase4.1 units/L1.2–7.6 units/L
C-reactive protein2.3 mg/L<0.5 mg/L
Anti-nuclear antibody (ANA)1:160 titer (speckled)<1:80 titer
Anti-SSA (Ro)6 units<20 units
Anti-SSB (La)2 units<20 units
Anti-double-stranded DNA (Crithidea indirect fluorescent antibody)negativenegative
Anti-Smith4 units<20 units
Anti-RNP16 units<20 units
C3 complement129 mg/dL79–152 mg/dL
C4 complement26 mg/dL15–46 mg/dL
Anti-neutrophil cytoplasmic antibody (ANCA)<1:20 titer<1:20 titer
Anti-cyclic citrullinated peptide IgG (ACPA)6 units<20 units
Rheumatoid factor<15 IU/mL<15 IU/mL
Hepatitis B surface antigennegativenegative
Hepatitis C antibodynonreactivenonreactive
Lyme antibody0.09<0.9
Urine blood<1/HPF0–2/HPF
Urine proteinnegativenegative
*abnormal findings indicated in bold

His prednisone was increased back to 40 mg/day, and electromyogram (EMG)/nerve conduction studies were ordered. Further laboratory testing demonstrated normal serum protein electrophoresis, hemoglobin A1c, B12 and thyroid-stimulating hormone. He did not have antibodies against syphilis, hepatitis B or hepatitis C. His EMG/nerve conduction test showed bilateral sensorimotor polyneuropathy with absent sural and diminished posterior tibial nerve responses, consistent with mononeuritis multiplex.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 | Single Page

Filed Under: Conditions, Vasculitis Tagged With: minocycline, polyarteritis nodosa, vasculitic neuropathyIssue: October 2020

You Might Also Like:
  • Case Report: A 50-Year-Old Man Suffers Dye-Induced Arthritis
  • Case Study: 66-Year-Old Man with Visual Loss, Headache, Hematuria, Chronic Sinusitis
  • Case Report: Metoprolol-Induced Arthralgia
  • Case Report: A COVID-19 Mimic

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)